NewswireToday - /newswire/ -
San Jose, CA, United States, 2006/06/12 - AnaSpec, a global producer of phosphopeptides, has made its own line of phosphoamino acids publicly available..
AnaSpec, Inc. is a leading provider of integrated proteomics solutions for worldwide life science research. With a vision for innovation through synergy, AnaSpec offers expertise in three primary technologies: peptides, detection reagents, and combinatorial chemistry. AnaSpec carries a broad product line of biochemicals and reagents for basic research, high-throughput screening and drug discovery. In conjunction, AnaSpec provides premier custom services including peptide synthesis, antibody production, and assay development. AnaSpec holds a California Drug Manufacturing License (License #41747) and a FDA Registration for GMP Drug Manufacturing (Registration #2951078).
The synthesis of phosphopeptides has witnessed significant advancements in recent years with the introduction of monobenzyl protected-phospho-amino acids, such as Fmoc-Phosphoserine, Fmoc-Phosphothreonine, and Fmoc-Phosphotyrosine. The use of these phospho-amino acids in standard Fmoc chemistries has resulted in high-yield, ultra-pure phosphopeptides, even in automated solid phase peptide synthesis. The industry’s leading manufacturer of phosphopeptides, AnaSpec, is offering the same line of phosphoamino acids that are the building blocks for AnaSpec’s world-class phosphopeptides for use in research facilities throughout the world.
Line of Phosphoamino Acids includes:
For more information, visit our website.